Allogene Therapeutics Inc (OQ:ALLO)

Business Focus: Biotechnology & Medical Research

Latest 10 SEC filings (by transaction date) for ALLO within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET August 23rd, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jul 30/19 Jul 30/19 Moore Alison Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -11,819  
Jul 30/19 Jul 30/19 Moore Alison Direct Ownership Common Stock S - Open market or private sale -11,819 $29.85
Jul 30/19 Jul 30/19 Moore Alison Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 11,819 $2.27
Jul 30/19 Jul 29/19 Moore Alison Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -23,815  
Jul 30/19 Jul 29/19 Moore Alison Direct Ownership Common Stock S - Open market or private sale -23,815 $29.39
Jul 30/19 Jul 29/19 Moore Alison Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 23,815 $2.27
Jul 30/19 Jul 26/19 Moore Alison Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -13,193  
Jul 30/19 Jul 26/19 Moore Alison Direct Ownership Common Stock S - Open market or private sale -13,193 $29.18
Jul 30/19 Jul 26/19 Moore Alison Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 13,193 $2.27
Jul 22/19 Jul 18/19 Kazam Joshua A Direct Ownership Common Stock J - Other transaction 8,217  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for ALLO within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET August 23rd, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jul 30/19 Jul 30/19 Moore Alison Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -11,819  
Jul 30/19 Jul 29/19 Moore Alison Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -23,815  
Jul 30/19 Jul 26/19 Moore Alison Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -13,193  
Jul 30/19 Jul 30/19 Moore Alison Direct Ownership Common Stock S - Open market or private sale -11,819 $29.85
Jul 30/19 Jul 30/19 Moore Alison Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 11,819 $2.27
Jul 30/19 Jul 29/19 Moore Alison Direct Ownership Common Stock S - Open market or private sale -23,815 $29.39
Jul 30/19 Jul 29/19 Moore Alison Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 23,815 $2.27
Jul 30/19 Jul 26/19 Moore Alison Direct Ownership Common Stock S - Open market or private sale -13,193 $29.18
Jul 30/19 Jul 26/19 Moore Alison Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 13,193 $2.27
Jul 22/19 Jul 18/19 Kazam Joshua A Direct Ownership Common Stock J - Other transaction 8,217  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $ALLO

StockTwits